Production of Gut Microbiota-Derived Metabolites in Response to Different Fatty Acid Profiles

NCT ID: NCT05917132

Last Updated: 2025-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-12

Study Completion Date

2024-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed project mainly aims to investigate the microbial processes leading to dietary metabolites production, independently of long-term microbiota adaptation to the diet, by measuring the microbiota-derived metabolite production from a meal sequence rich in saturated fatty acids (SFA) or the same meals but rich in polyunsaturated fatty acids (PUFA) in individuals with or without obesity and Type 2 diabetes (T2D)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The gut microbiota interacts with the host's enteric and systemic functions through the production of gut microbiota-derived metabolites. A subset of these metabolites, the endocannabinoids (eCB) and their congeners are derived from fatty acids and play a crucial role in metabolic health.

The research project aims to study gut microbiota-derived metabolites, including the eCB and their congeners, in response to a 2-day diet rich in polyunsaturated fatty acids or rich in saturated fatty acids in individuals with or without abdominal obesity and type 2 diabetes.

The investigators hope to better understand the kinetic production of circulating endocannabinoidome mediators derived from fatty acids in the diet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity, Abdominal Diabete Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SEQUENTIAL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single

All participating subjects will undergo 3 feeding phases : 3 days of a run-in diet, 2 days of a polyunsaturated fatty acid (PUFA) diet and 2 days of a saturated fatty acid (SFA) diet.

Group Type EXPERIMENTAL

Nutritionnal intervention

Intervention Type OTHER

Participants will be provided with meals corresponding to each diet during the week. Participants will be required to eat only the meals provided.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutritionnal intervention

Participants will be provided with meals corresponding to each diet during the week. Participants will be required to eat only the meals provided.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged between 45 and 65 years, menopaused women ;
* Body mass index between 20 to 35 kg/m² ;
* General good health ;
* Score of diet quality (HEI) between 40 and 70 ;
* Computer and Internet access ;
* Basic understanding of written French ;
* Daily stool frequency.

Exclusion Criteria

* Intestinal pathologies including inflammatory bowel disease and gastrointestinal cancers ;
* Alcohol consumption greater than 15 portions for men and 10 for women weekly.
* Active tobacco and cannabis usage ;
* Consumption of omega-3 dietary supplements ;
* Consumption of dietary supplements (vitamins and probiotics) - must be ceased 2 weeks before the dietary intervention ;
* Completion of a course of antibiotics in the past 3 months ;
* Important weight change (+/- 5 kg) in the past 6 months ;
* Type 1 diabetes or insulin-treated diabetes.
Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alain Veilleux

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alain Veilleux, PhD

Role: PRINCIPAL_INVESTIGATOR

Laval University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut sur la nutrition et les aliments fonctionnels - INAF

Québec, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-109

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Precision Nutrition and Metabolic Function
NCT04131166 ACTIVE_NOT_RECRUITING NA
UBC Breakfast Study 2.0
NCT06814171 RECRUITING NA
Controlled Feeding Experiment
NCT00951756 COMPLETED NA